期刊文献+

酮康唑纳米晶体的制备及溶出性能考察 被引量:1

Preparation and dissolution of ketoconazole nanocrystals
下载PDF
导出
摘要 采用高压均质法制备酮康唑纳米晶,考察稳定剂种类及浓度、酮康唑浓度、高压均质机运行压力以及均质化循环次数对粒径和多分散指数的影响。结果表明,最优制备工艺为:10%(相对主药量)的泊洛沙姆407作为稳定剂,酮康唑浓度10 mg/m L,运行压力81.6 MPa,循环次数15次。优化条件下制得的酮康唑纳米晶平均粒径为120 nm,而且研磨前后药物的晶态及化学结构没有明显改变;与原料药相比,纳米晶的溶解度、溶出速率、溶出总量均有了显著地提高。 High pressure homogenization method was employed to prepare ketoconazole nanocrystals. The influence of drug concentrations,types and concentrations of stabilizer,the pressure and circle numbers on particle size and polydispersity index were investigated. Results showed that the optimized process parameters were as follows: the concentration of stabilizer is 10%,the concentration of drug is 10 mg / m L,the pressure is 81. 6 MPa,and the circle numbers is 15. Ketoconazole nanocrystals with an average size of120 nm can be obtained in the optimum condition. Furthermore,both drugs before and after milling maintained original crystalline state; compared to ketoconazole bulk,the dissolution rate and solubility of drug nanocrystals showed a significant increase.
出处 《应用化工》 CAS CSCD 北大核心 2016年第9期1672-1676,共5页 Applied Chemical Industry
基金 河北省高等学校科学技术研究项目(ZD2014079) 河北省自然科学基金资助项目(H2014208151)
关键词 酮康唑 纳米晶 高压均质 溶解度 溶出速率 ketoconazole nanocrystals high pressure homogenization solubility dissolution rate
  • 相关文献

参考文献14

  • 1尚北城,徐贵丽,张青,简晓娜,李志远.酮康唑微囊的制备及其药剂学研究[J].西南国防医药,2004,14(3):251-255. 被引量:5
  • 2Abu T M Serajuddin.Salt formation to improve drug solubility[J].Advanced Drug Delivery Reviews,2007,59:603-616.
  • 3Ernst Binderup,Fredrik Bjorkling,Pernille Vig Hjarnaa,et al.EB1627:a soluble prodrug of the potent anticancer cyanoguanidine CHS828[J].Bioorganic&Medicinal Chemistry Letters,2005,15:2491-2494.
  • 4Xi Han,Chinmay Ghoroi,Daniel To,et al.Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles[J].International Journal of Pharmaceutics,2011,415:185-195.
  • 5王廉卿,戎欣玉,刘魁,胡易,高倩,赵树春,李校根,张于驰.纳米药物晶体的制备技术及其应用[J].河北科技大学学报,2014,35(4):339-348. 被引量:21
  • 6郑爱萍,石靖.纳米晶体药物研究进展[J].国际药学研究杂志,2012,39(3):177-183. 被引量:26
  • 7蔡霞,刘春燕,吕慧侠.纳米药物制备工艺与设备研究进展[J].机电信息,2011(8):5-11. 被引量:6
  • 8Filippos Kesisoglou,Santipharp Panmai,Wu Yunhui.Nanosizing-oral formulation development and biopharmaceutical evaluation[J].Advanced Drug Delivery Reviews,2007,59:631-644.
  • 9Peng Liua,Rong Xinyu,Johanna Laruc,et al.Nanosuspensions of poorly soluble drugs:Preparation and development by wet milling[J].International Journal of Pharmaceutics,2011,411:215-222.
  • 10Ranjita Shegokar,Rainer H Müller.Nanocrystals:Industrially feasible multifunctional formulation technology for poorly soluble actives[J].International Journal of Pharmaceutics,2010,399:129-139.

二级参考文献162

共引文献76

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部